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Abstract Nonobstructive azoospermia (NOA) is characterized by the complete absence of
sperm in the ejaculate due to testicular failure. The evaluation and management of patients
with NOA offer a challenge to the reproductive urologist. In the era of in vitro fertilization with
intracytoplasmic sperm injection, surgical sperm extraction techniques can afford men with
NOA biologic paternity. To provide a comprehensive review of surgical sperm retrieval ap-
proaches in the patient with NOA emphasizing complications, success rates and outcome opti-
mization, a Medline search was conducted querying surgical approaches used to manage NOA.
Four sperm extraction techniques are described including: testicular sperm aspiration, testic-
ular sperm extraction, fine needle aspiration mapping and microdissection testicular sperm
extraction. In addition, the roles for pre-extraction varicocelectomy and sperm cryopreserva-
tion are discussed. The management of NOA continues to evolve as newer tools become avail-
able. Several modalities of sperm acquisition exist. An understanding of their complications
and success rates is fundamental to the treatment of NOA.
ª 2015 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Azoospermia is characterized by the complete absence of
sperm in the ejaculate, affecting up to 15% of men seeking
an infertility evaluation. Approximately 60% of cases of
azoospermia are caused by primary or secondary hypo-
gonadism, termed nonobstructive azoospermia (NOA) [1].
Possible etiologies span a spectrum including genetic dis-
orders or local testicular insults [2,3] that result in impaired
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spermatogenesis or disruption of the hypothalamic-
pituitary-testis (HPT) axis. The conditions leading to NOA
represent some of the most challenging of infertility
management.
Although the underlying cause of NOA may be occa-
sionally correctable (i.e., hypogonadotrophic hypo-
gonadism), most of these patients will require advanced
reproductive technologies. With the introduction of
in vitro fertilization (IVF) and intracytoplasmic sperm
injection (ICSI) in the 1990s, many of these men can now
father their own biologic children. IVF-ICSI combined
with sperm extraction techniques are now considered
standard practice and are conducted routinely
worldwide.
For successful IVF-ICSI only a few viable sperm are
required. In those patients with NOA, even very low levels
of spermatogenesis can be exploited with surgical sperm
extraction. Several techniques to retrieve sperm from the
testes have been described, each with a unique set of ad-
vantages and disadvantages. In this review we summarize
the surgical management of NOA and seek to clarify the
implications of each approach.
2. Initial evaluation
A diagnosis of azoospermia is made after two separate
semen analyses demonstrate the lack of spermatozoa in
centrifuged specimens. An interval of at least 3 weeks
should be allowed to pass between samples. It is important
to rule out possible collection error or retrograde ejacula-
tion when interpreting samples with low volumes (less than
1.5 mL). Once azoospermia is confirmed, one must differ-
entiate between obstructive or nonobstructive etiologies.
A thorough history and physical examination provide the
basis for further testing. A focused history investigates the
inherent endocrine and exocrine function of the testes.
Symptoms consistent with low testosterone may represent
deficiencies in androgen production, often found in
conjunction with NOA. A prior history of paternity should
not be considered specific to either form of azoospermia.
The clinician should also inquire about risk factors that may
help guide further evaluation (Table 1).
A detailed physical exam will often secure the diagnosis.
The general exam can be useful in detecting stigmata of an
endocrinopathy or genetic abnormality with particular
awareness to gynecomastia and signs of impaired viriliza-
tion. Careful attention should be paid to the scrotal exam.
Surgical scars in the scrotum and inguinal region may pro-
vide evidence for prior surgery. Palpation of the spermatic
cord allows the identification of possible varicoceles and to
ensure the presence of both vasa deferentia. Decreased
testicular volumes (below 15 mL) substantially raise suspi-
cion for NOA. Finally, a digital rectal examination can be
helpful in palpating obstructing midline cysts or fullness of
the seminal vesicles.
Initial laboratory testing includes morning serum
testosterone and follicle stimulating hormone (FSH) levels
to help delineate the health of the Leydig and Sertoli cells,
respectively. An FSH level above 7.6 mIU/mL supports an
NOA diagnosis [4]. Any abnormalities on initial screening
should prompt a full evaluation of the HPT axis. Classically,
NOA patients will have normal volume, normal pH, azoo-
spermic semen analyses with small-volume testes and an
elevated FSH. Karyotype and Y chromosome microdeletion
testing should be obtained in any patient with suspected
NOA as chromosomal abnormalities are common in this
population [5].
3. Evidence acquisition
A Medline search was conducted using the following search
terms: nonobstructive azoospermia, sperm retrieval,
testicular sperm extraction, fine needle aspiration, fine-
needle mapping, testicular sperm aspiration, microdissec-
tion testicular sperm extraction, and cryopreservation. This
search aimed to identify randomized, observational and
descriptive studies describing the surgical management of
NOA patients. As no randomized trials were available,
observational and descriptive studies are discussed in this
review.
A total of four techniques were commonly addressed and
are described below, including testicular sperm aspiration
(TESA), traditional testicular sperm extraction (TESE), fine
needle aspiration (FNA) mapping, and microdissection
testicular sperm extraction (microTESE). Two adjunctive
procedures e cryopreservation and the role of varicoce-
lectomy e are also discussed in the context of NOA
management.
4. Evidence synthesis
4.1. TESA
Testicular sperm can be retrieved via percutaneous aspi-
ration of testicular tissue. This technique was initially
described for diagnostic purposes before it was adapted as
a therapeutic approach [6]. The sample is acquired by
aspirating through a fine (22-gauge) or large bore (18-
Table 1 Risk factors for azoospermia.
Type of
azaspermian
Risk factors
Nonobstructive
azoospermia
Cryptorchidism
Delayed puberty
Chemotherapy or radiation
Testosterone replacement therapy
Anabolic steroid abuse
History of orchitis (mumps)
Toxin exposure (heavy metals,
pesticides)
Obstructive
azoospermia
Prior scrotal surgeries
Inguinal hernia repair
Recurrent respiratory tract infection
(cystic fibrosis, Young syndrome)
Pelvic/scrotal trauma
Reproductive malformation (prostatic
cyst, absence of the vasa deferentia)
History of epididymitis
History of prostatitis
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gauge) needle after puncturing the testis through the
scrotal skin. Samples of testicular parenchyma are subse-
quently immersed in human tubal fluid medium and me-
chanical disruption is performed [7].
The success of sperm procurement with this approach
has been evaluated by several studies. Lewin et al. [8]
treated 85 men with NOA via TESA and reported a sperm
retrieval rate (SRR) of 58.8%. Khadra et al. [9] evaluated
the outcomes of 84 men who underwent TESA and reported
an SRR of 53.6%. Patients in this cohort who failed TESA
then proceeded to open testicular biopsy in a rescue effort
at sperm recovery. The TESA-only group had a higher
fertilization rate (62% vs. 48%) but this difference did not
significantly impact clinical pregnancy rates (40% vs. 32%,
p > 0.05).
TESA offers a modest SRR permitting IVF-ICSI. In some
centers, TESA has become the initial option given its
minimally invasive approach and relatively small risk for
parenchymal damage and testicular tissue loss. The pro-
cedure can be done with local anesthesia, mitigating the
need for a full operating room while preserving the comfort
of the patient [10]. Minor side effects were described
including hematocele and post-operative orchialgia, typi-
cally managed with oral analgesics [8,9,11]. However,
despite its safety, low cost, and ease, controlled studies
have shown a much lower success rate compared with the
more invasive procedures described below [12].
4.2. TESE
In order to improve the SRR in men with NOA, a larger
sample of testicular tissue can be harvested and processed.
TESE achieves this goal through open testicular biopsy via
either a single or multi-site approach. This technique is
more invasive as compared to TESA, requiring scrotal
exploration. A small incision in the tunica albuginea is
created avoiding any vessels, and the testis is gently com-
pressed causing protrusion of the parenchyma. The
extruded seminiferous tubules are excised and processed in
a similar fashion as TESA [7]. Additional samples can be
collected from the same incision or via separate sites if
more tissue is required.
Available literature regarding TESE has stratified SRRs
based upon underlying testicular histopathology since this
information is readily available. Su et al. [13] reported a
total SRR of 58% in 81 men who underwent TESE. Results
varied substantially by histological pattern, with the high-
est SRR in the group with hypospermatogenesis as opposed
to maturation arrest (MA) or Sertoli cell only (SCO) (79%,
47%, and 29%, respectively). In another report, Hauser
et al. [12] attempted TESE in a group of 87 patients, suc-
cessfully procuring sperm in 64% of the overall cohort. The
SRR stratified by histology was 100% in hypospermatogenic
males, with a considerable drop to only 46% and 33% in MA
and SCO, respectively.
A recent paper by Abdel Raheem et al. [14] found a strong
correlation between the presence of tubules with sperma-
tozoa on histopathologic evaluation and success during TESE.
In patients with hypospermatogenesis there was a 100% SRR
with TESE, in contrast to only 24% in SCO, corroborating
previous reports. The authors went on to suggest attempting
pre-emptive TESE prior to the start of IVF-ICSI. Results will
provide histologic information and any recovered sperm can
be cryopreserved for use during egg retrieval. For those pa-
tients in whom sperm could not be found at initial TESE, the
histopathologic findings can help stratify those who may be
candidates for repeat fresh TESE versus more invasive pro-
cedures (e.g., microTESE), or consideration of donor sperm
backup at the time of oocyte retrieval.
Differing SRRs have been reported depending upon un-
derlying patient risk factors. A recent study from Marcelli
et al. [15] evaluated 142 patients with a history of crypt-
orchidism and found an overall SRR of 65% at the time of
TESE. This study also showed that the age at orchidopexy
did not influence SRR. Reasonable success using TESE has
also been demonstrated in those individuals with Klinefel-
ter syndrome. Vernaeve et al. [16] studied 50 non-mosaic
Klinefelter patients and reported a 48% SRR. A systematic
review by Fullerton et al. [17] included 373 men with Kli-
nefelter syndrome who were managed using various surgi-
cal modalities. They reported a 42% SRR in the group that
underwent TESE.
Given the heterogeneity of testicular spermatogenesis,
the rationale of a single biopsy site as opposed to multiple
biopsies has been questioned. A large study of 306 men by
Amer et al. [18] attempted to address this issue. They split
their cohort into either single or multiple-site biopsy arms
and demonstrated a higher success rate with multiple-site
biopsies (38% vs. 49%). Although supportive for the
multiple-site approach, their patients were not randomized
which impedes definitive conclusions from their analysis.
TESE has been heralded to have better SRRs than TESA
[12]. However, complications occur more frequently with
TESE, including scrotal hematomas and, rarely, testicular
atrophy. Extratunical hematomas are observed in 5% of
patients and are usually self-limited [19]. Intratunical he-
matomas, although often asymptomatic, can be seen on
82% of ultrasounds and may take up to 6 months to
completely resolve. Testicular devascularization and
resulting atrophy is uncommon, occurring in 3% of reported
cases. This complication is commonly attributed to
multiple-site TESE procedures since separate arteries can
be interrupted [20]. Although some reports show vascular
damage from TESE, Schill et al. [21] did not find significant
differences between pre- and post-TESE testicular volumes
(by ultrasound) in 39 patients.
4.3. FNA mapping
Despite efforts to improve TESE there remains a significant
failure rate. The experience with multiple-site testicular
biopsies has shown that spermatogenesis is not homoge-
nous. There are areas in the testicular parenchyma where
sperm production is preserved, even in those patients with
severe histopathology. Unfortunately, performing multiple
testicular biopsies may raise the risk of testicular atrophy.
In order to target biopsies for sperm retrieval and reduce
the chances of deleterious effects, the concept of FNA
mapping was introduced by Turek et al. [22]. The initial
mapping procedure is often conducted under local anes-
thesia in the office setting. The surgeon directs multiple
percutaneous punctures into the testis with a fine (23-
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gauge) needle in an attempt to aspirate parenchyma and
sample various regions of the testis. Up to 18 template-
guided sites are sampled and analyzed for sperm. Any
positive aspirates favor successful sperm retrieval at that
location. Thus, a few targeted open testicular biopsies can
be conducted without the additional risk of multiple blind
attempts [23]. When FNA mapping confirms multiple sites
with sperm, the reported success of TESE reaches 99% in a
single surgeon’s experience. If few areas demonstrate
spermatogenesis, TESE success remains favorable with SRR
approaching 90%. In the case of zero or one positive sam-
pling, the success of TESE is debatable and more invasive
procedures should be considered [24].
Regarding outcomes, FNA mapping has proven safe, with
one series showing no hematomas on follow-up ultrasounds
[22]. Moreover, there were no reported cases of testicular
atrophy, no significant decrease in testosterone, or appre-
ciable changes in testicular volumes 3 months following
the procedure [25]. In a heterogeneous group of 56 pa-
tients, FNA mapping demonstrated an SRR of approximately
70% [26].
4.4. MicroTESE
In an attempt to further optimize testicular SRRs over those
achieved with TESE, microTESE was developed in an effort
to capitalize on success rates of multi-site excisional biopsy
while aiming to limit the amount of tissue excised. Initially
described by Schlegel [27], he postulated that bivalving the
testis and using optical magnification would allow the sur-
geon to minimize testicular trauma, maximize exposure for
a complete exploration and dissection of the seminiferous
tubules, and identify specific regions that might harbor
preserved spermatogenesis.
The testis is delivered via a scrotal incision. With the
assistance of the operating microscope, a transverse
hemispheric incision is made into the tunica albuginea with
an attempt to avoid transection of subtunical vessels. The
testicle is then gently bivalved to expose the seminiferous
tubules. The operating microscope is utilized at 20e40
magnification to identify plump and opaque seminiferous
tubules that are more likely to contain sperm. In circum-
stances that initially fail to provide retrievable sperm, the
testis can be completely surveyed and dissected in an effort
to maximize any yield. Again, if sperm are not found, the
surgeon proceeds to the contralateral testis in a similar
fashion.
This technique has been shown to provide a better SRR
than single or multi-site TESE. Despite its invasive nature,
the optical magnification allows for rational tissue sampling
and typically results in less overall tissue removal. Superior
hemostasis can also be achieved since blood vessels can be
directly visualized and either avoided or cauterized with
the bipolar microforceps, decreasing risk of vascular injury
and resulting atrophy. In one of the initial descriptions of
the technique, a retrieval rate of 63% was obtained when
compared to 45% for traditional TESE [27]. Amer et al. [28]
directly compared microTESE with TESE by performing one
procedure on one testis and the counter technique on the
opposite side. This study reported similar results with an
improvement in SRR (30% with TESE vs. 47% with
microTESE).
Testicular histology also correlates with SRRs for micro-
TESE. In one series, patients with SCO had yields of 22%
with microTESE as compared to 13% using multi-site TESE
[29]. In another series with 460 patients SRR via microTESE
was 81% in those with hypospermatogenesis, 44% with MA,
and 41% with SCO as the predominant histologic pattern
[30].
One group investigated the use of microTESE as a salvage
procedure following multiple unsuccessful TESE attempts.
They reported that SRRs were not adversely affected
following one or two prior TESE attempts. However, three
or four previous TESE procedures did lead to decreased
retrieval rates with microTESE, although spermatozoa were
still found in 23% of these patients [31].
Given the significant costs of IVF-ICSI and the emotional
toll that accompanies a treatment cycle, multiple attempts
have been made to develop predictors of SRR. A multi-
institutional cohort of 1026 men was analyzed by Ram-
asamy and colleagues [32] for this purpose. Although mul-
tiple parameters were found to correlate with favorable
SRR, no indicator was found to be accurate enough to allow
for meaningful clinical decisions. Even testicular volume
has been found to be a poor predictor in regards to SRR.
Bryson et al. [33] evaluated the impact of testicular volume
on microTESE success. They observed that NOA patients
with severe testis atrophy, specifically with testicular vol-
umes of 2 mL or less, had the same SRR as patients with
volumes above 10 mL (55% vs. 55%).
4.4.1. Subpopulation success rates with microTESE
The specific populations identified within the Ramasamy
cohort have also been separately studied with promising
results. Patients with a history of cryptorchidism can ach-
ieve good retrieval rates with microTESE. Raman and
Schlegel [2] reported on 38 men submitted to 47 microTESE
attempts with a resulting 74% SRR. This same cohort ach-
ieved clinical pregnancy in 46% of those with procured
sperm. Contrary to a prior study, it was noted that SRR is
related to the age at which orchidopexy was performed.
Patients who had sperm successfully retrieved had typically
undergone orchidopexy by 10 years of age. Another study
from a similar cohort demonstrated a 64% SRR and 38% live
birth rate [34].
MicroTESE has also proven successful in those patients
with non-mosaic Klinefelter syndrome. An initial report
evaluated 42 patients with successful sperm extraction in
29 of the subjects (69% SRR). A total of 21 live births
resulted from IVF-ICSI cycles that utilized the retrieved
sperm [35]. Another study addressed predictors of sperm
retrieval within this population, revealing that subjects
who responded to testosterone optimization (using aroma-
tase inhibitors, selective estrogen receptor modulators,
and/or human chorionic gonadotropin) had better SRRs
(77% vs. 55%) [36]. Fullerton et al. [17] reviewed cases re-
ported in the literature and identified 101 live births from
Klinefelter syndrome patients who had sperm extracted via
TESE or microTESE. All babies born were genetically
normal.
With increasing frequency older men are becoming
interested in family building. A retrospective study evalu-
ated 1066 men with NOA and stratified them based upon
age at the time of microTESE. The two groups had a mean
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age of 57 and 43, respectively. This report did not show a
negative relationship between age and SRR, and on the
contrary, older patients had higher rates of sperm retrieval
(73% vs. 56%) [37]. Although this is a retrospective series,
this study shows that microTESE provides a reasonable op-
tion for the older male seeking fertility in the setting of
NOA. However, the converse may be true in patients with
Klinefelter syndrome. From a study of 74 patients, Kline-
felter patients with successful sperm retrieval were
significantly younger, an important finding to consider when
counseling this subpopulation [38].
4.4.2. MicroTESE complications
Complications of microTESE include hematoma and intra-
testicular fibrosis. In a series of 60 patients who underwent
the procedure, 15% had intratesticular hypoechoic focal
lesions on post-operative ultrasound. When followed with
serial ultrasounds the rate reduced to 6% at 1 month and
completely resolved by 6 months of follow-up [28]. Simi-
larly, a study with a cohort of 100 men demonstrated a
hematoma rate of 12% on 1-month ultrasound, dropping to
2.5% at 6 months post-operatively [39]. Ramasamy et al.
[30] reported a higher frequency of hematoma after
microTESE, demonstrating a positive finding in 44% of pa-
tients who underwent ultrasound 3 months following the
procedure. Again, nearly all of these hematomas had
resolved by 6 months. More worrisome was a description of
segmental devascularization that was discovered in four
patients. None of these patients was ultimately found to
have permanent vascular changes. In a large meta-analysis,
although sonographic complications seemed higher, there
were no differences in clinically evident complications
between conventional TESE and microTESE [40].
In those patients from whom large amounts of testicular
parenchyma must be sampled, microTESE has been found
to potentially result in atrophy and impaired testis func-
tion. Okada et al. [39] reported decreased testicular vol-
umes in two of 80 men who underwent microTESE.
However, this finding was not corroborated by Amer et al.
[28] who reported that testicular volumes remained un-
changed in 116 patients. Ramasamy et al. [30] reported a
20% decrease of serum testosterone shortly after the pro-
cedure; however, serum levels returned to pre-procedural
levels in 85% and 95% of men at 12 and 18 months,
respectively. It should be mentioned that in the subpopu-
lation of patients with Klinefelter syndrome, testosterone
levels may remain decreased for longer periods of time as
demonstrated by Takada et al. [41].
A recent meta-analysis comparing conventional TESE
with microTESE utilized the data from seven independent
studies. The data, although predominately retrospective,
did favor microTESE (54% vs. 33% SRR) [40]. Interestingly,
patients with hypospermatogenesis may not experience as
much of a benefit given that conventional TESE can already
achieve high SRRs. Often, however, a histopathothologic
diagnosis is not known prior to sperm retrieval attempt.
4.5. Cryopreservation
IVF-ICSI can be performed using frozen-thawed sperm. The
use of cryopreserved sperm has logistical advantages and
eliminates the need for concurrent oocyte and sperm
retrievals. Unfortunately survival rates for frozen testicular
sperm have been low in historical studies [42]. In addition,
IVF-ICSI outcomes may be impaired as Aoki et al. [43]
demonstrated in a retrospective evaluation of 92 cycles.
Laboratory pregnancy rates (60% vs. 49.1%), clinical preg-
nancy rates (56.4% vs. 41.2%), and live birth rates (48.7% vs.
31.2%) were each higher in the fresh versus the frozen
groups.
Recent data have questioned the superiority of fresh
samples. Karacan and colleagues [44] evaluated the
outcome of 337 IVF-ICSI cycles in which 129 employed
frozen testicular sperm. There was no difference in clinical
pregnancy or live birth rates. Tavukcuoglu et al. [45]
evaluated the impact of frozen sperm in 39 IVF-ICSI cycles
compared to fresh testicular sperm in 43 cycles. Again,
there was no significant difference observed in clinical
pregnancy or live birth rates.
A current systematic review included 10 studies assess-
ing fertilization rates and 11 that evaluated clinical preg-
nancy rates. In total, 574 cycles were analyzed, 299 of
which were conducted with frozen sperm. Results show
that outcomes using frozen-thawed testicular sperm do not
differ compared with freshly extracted sperm in terms of
fertilization or live birth rates [46]. At this time a consensus
has not been met, and therefore use of frozen testicular
sperm remains a debated topic.
4.6. Varicocelectomy in NOA
Varicocele repair has a controversial role in men with
NOA. There are some authors who advocate that repair
can result in an improvement of spermatogenesis and may
possibly return sperm to the ejaculate, or at least improve
SRRs during an extraction attempt. Others report that
these data represent only a transient reemergence of
spermatogenesis as is observed in some azoospermic pa-
tients without varicocele. In an initial report of micro-
surgical varicocelectomy, a small series of 27 patients
with NOA and palpable varicocele demonstrated post-
operative sperm on semen analysis in 33% of subjects. In
this series one patient achieved spontaneous conception.
Six of these patients reverted to azoospermia within 6
months following the procedure [47]. Another small study
included 23 men with non-palpable varicoceles. Similarly,
following repair 30% of the group had return of motile
sperm to the ejaculate. One patient conceived sponta-
neously and two others underwent successful ICSI using
ejaculated samples [48].
Abdel-Meguid [49] attempted to study the effects of
varicocele repair when patients were stratified by histo-
pathologic diagnosis. By taking a testicular biopsy at the
time of varicocelectomy they demonstrated reversal of
azoospermia in 53% and 50% of men with hypospermato-
genesis and MA, respectively. There was no improvement
in those with SCO. A meta-analysis including 233 patients
with NOA from 11 studies reported return of motile
ejaculated sperm in 39% of men following varicocelec-
tomy. Success rates were more favorable in patients
with hypospermatogenesis (54%) or MA (42%) than SCO
(11%). Moreover, 11 spontaneous pregnancies were re-
ported [50].
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In contrast, one study described equivalent SRRs in
those who underwent varicocelectomy as opposed to no
intervention. Additionally, only 9.6% of men with vari-
cocele repair had enough sperm return to the ejaculate
to avoid subsequent surgical sperm retrieval [51]. The
lack of controlled and randomized studies weakens the
data and represents the major criticism for the use of
varicocelectomy as an adjunct. Varicocele repair may
benefit some patients with NOA but definitive data will
need to be acquired before this subgroup can be fully
elucidated.
5. Conclusion
Over the past several decades, treatment of men with NOA
has benefited from an expanding knowledge base and the
concomitant development of refined surgical techniques.
Once impossible, men with NOA can now realistically hope
to father their own biologic children. Reasonable pregnancy
rates can be achieved using a variety of surgical approaches
that vary from office-based percutaneous procedures to
technically demanding microsurgery. Many couples have
been given hope with these procedures, although there
remains a proportion of men who will not have successful
treatment. Future advances in the field will help diminish
this group as our understanding of NOA evolves.
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